$MRNA · Benzinga · 2026-10-30
MRNA 不是一只值得持有的股票：它从未赚过钱，是一家“忽悠”公司，不过日内进出交易尚可。它此前表现强劲——上涨 545%，随后 William Blair 将其下调至 market perform——而 180 是良好的逢低买入点。
逐段跳播
MRNA，只跌了几个点。
MRNA, only down a couple.
哇。MRNA。对。mRNA 在哪？mRNA 没有下跌。William Blair 对 Madna 股票出手，在上涨 545% 之后将评级下调至 market outperform。
那是 10 月 27 日，所以那不是，对，那看起来确实很强。
Wow. MRNA. Yeah. Where is mRNA? mRNA is not going down. William Blair takes a shot at Madna stock downgrade to market outperform after 545% run. That was October 27th, so that's not Yeah, that that looks strong for sure.
你觉得 MNA、MRNA 怎么样？它就是看起来不错。180 那次真是绝佳的逢低买入机会。我在 180 进场了。不过它从 240 因消息泄露而下跌时，我持有得不够久。那是一个很好的机会。
Uh, what do you think of MNA MRNA? It's just looking good. You know, that was such a buy the dip at 180. I got involved at 180. I didn't hold it long enough though when it went down from 240 on the leaked news. That was that was a good opportunity.
只不过 MRNA 涨了 1.15 美元。我的天。我讨厌这些家伙。我真的讨厌。对。我就是觉得他们从来没赚过钱。而且他们就是那种忽悠人的公司。如果你只是交易它，说“嘿，我当天进当天出”，那完全没问题。但在我看来，它绝对不是值得持有的东西。
Except MRNA is up a$1.15. Oh my gosh. Um and I hate those guys. I do. I hate Yeah. I just feel like they've never made any money. Uhhuh. Um, and they are, you know, they're just one of those flim flam companies.
You, if you just trade it and you say, "Hey, I'm going in and out for the day, then perfectly fine." But it's definitely not something to hold in my mind.
这个频道对 $MRNA 的历次判断
Benzinga 在这只股票上共 5 条判断，这里只列相邻的几条。